Director, Logistics Engineering
WhatNotFull Time
Expert & Leadership (9+ years)
The Manager, Logistics Engineering role requires a strong understanding of global cold chain and distribution capabilities, with a focus on Good Distribution Practices (GDP) and regulatory guidelines. Experience in deploying and optimizing logistics strategies for pre-clinical, clinical, and commercial product lines is essential. The ideal candidate will be a subject matter expert in cold chain practices, possess knowledge of real-time visibility, IoT analytics, and digital innovation, and have experience authoring GMP-compliant documentation such as SOPs and Work Instructions. Collaboration with manufacturing, logistics, quality teams, and external partners, along with experience in technology transfers and vendor qualification, is also required. Staying current with industry trends and regulatory shifts is crucial.
The Manager, Logistics Engineering will deploy, maintain, and oversee Moderna’s International Logistics Engineering strategy and cold chain requirements. Responsibilities include serving as the global owner for shipping systems and methods, leading logistics engineering visibility projects, and authoring GMP-compliant documentation. The role involves providing expert advice on cold chain handling, storage, and transportation, supporting the implementation and qualification of new shipping systems, and overseeing technology transfers at partner sites. Additionally, the manager will provide training, develop and monitor KPIs, act as an SME during audits, collaborate with External Quality for vendor qualification, and contribute to innovation-driven projects.
Develops mRNA-based medicines for health
Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.